Chapter

Deprescribing Mood Stabilizers

Swapnil Gupta, Rebecca Miller and John D. Cahill

in Deprescribing in Psychiatry

Published on behalf of Oxford University Press

Published in print September 2019 | ISBN: 9780190654818
Published online July 2019 | e-ISBN: 9780190929480 | DOI: https://dx.doi.org/10.1093/med/9780190654818.003.0010
Deprescribing Mood Stabilizers

Show Summary Details

Preview

This chapter reviews the literature on lithium withdrawal and provides strategies on how to reduce the risk of relapse through such measures as slow tapers. Combinations of mood stabilizers such as lithium, divalproex, carbamazepine, and lamotrigine are used frequently and recommended even with the approval of several second-generation antipsychotic medications as mood stabilizers. As patients grow older, the potential nephrotoxicity and hepatotoxicity of these medications can become a significant consideration. The question of misdiagnosis of mood instability and off-label use occurring in personality disorders and substance abuse is also addressed. Psychotherapeutic interventions such as psychoeducation, family therapy, and cognitive behavioral therapy that support the treatment of bipolar disorder are described as a part of the deprescribing process and illustrated by case examples.

Chapter.  4363 words. 

Subjects: Psychiatry ; Psychology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.